SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR+51.4%
5Y CAGR+2.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+51.4%/yr
vs -19.6%/yr prior
5Y CAGR
+2.2%/yr
Recent acceleration
Acceleration
+71.0pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $918.85M | +128.2% |
| 2025 | $402.64M | -47.7% |
| 2024 | $769.21M | +190.3% |
| 2023 | $264.95M | -73.2% |
| 2022 | $989.61M | +19.9% |
| 2021 | $825.62M | +19.1% |
| 2020 | $693.37M | +9.4% |
| 2019 | $634.00M | +1.2% |
| 2018 | $626.36M | -60.7% |
| 2017 | $1.59B | - |